Chokan Baimukhamedov

5 ta ish

South Kazakhstan Medical Academy Shymkent Kazakhstan

1. Increasing autoimmune rheumatic diseases as a consequence of the <scp>COVID</scp>‐19 pandemic: A hypothesis or fact?

   Chokan Baimukhamedov, Galymzhan Togizbayev, Khilola Mirakhmedova +2

   Tahririyat maqolasiAutoimmune and Inflammatory Disorders ResearchInternational Journal of Rheumatic Diseases20232 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.310338

2. Long COVID: the time has come for globally acceptable definitions

   Chokan Baimukhamedov, Khilola Mirakhmedova, Gulzhan Dossybayeva

   BoshqaLong-Term Effects of COVID-19Rheumatology International20232 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.381708

3. COVID-19 is a trigger of autoimmune rheumatic diseases: a hypothesis tested over time

   Aisulu Karkabayeva, Khilola Mirakhmedova, Shoira Khusinova +2

   BoshqaDermatological and COVID-19 studiesRheumatology International20240 iqtibos

   ABIABI:AkademIndex/openalex/2024.other.000004

4. Consensus Statement on the Management of Patients With Asymptomatic Hyperuricemia in General Medical Practice

   О. М. Драпкина, Mazurov Vi, Martynov Ai +23

   MaqolaGout, Hyperuricemia, Uric AcidHERALD of North-Western State Medical University named after I I Mechnikov20250 iqtibos

   ABIABI:AkademIndex/openalex/2025.article.005335

5. Late‐onset rheumatoid arthritis versus elderly‐onset rheumatoid arthritis: understanding the key differences: comment on the article by Lee et al

   Galymzhan Togizbayev, Chokan Baimukhamedov, Galiya Аssanova +2

   BoshqaRheumatoid Arthritis Research and TherapiesACR Open Rheumatology20250 iqtibos

   ABIABI:AkademIndex/openalex/2025.other.000001